Recombinant interferon‐alfa therapy in children with chronic hepatitis C
Flavia Bortolotti, Raffaella Giacchino, Pietro Vajro, Cristiana Barbera, Carlo Crivellaro, Alfredo Alberti, Gabriella Nebbia, Lucia Zancan, Lorena de Moliner, Adalberto Bertolini, Fiorella Balli, Francesco Callea – 1 December 1995 – The efficacy of recombinant interferon‐alfa therapy in children with chronic hepatitis C has been evaluated in a randomized, controlled pilot study including 27 patients, aged 2 to 14 years, without underlying systemic diseases.